C4 Therapeutics, Inc.
Clinical trials sponsored by C4 Therapeutics, Inc., explained in plain language.
-
New hope for myeloma patients: testing a powerful drug duo
Disease control Recruiting nowThis study is testing the safety of a new two-drug combination for people with multiple myeloma that has come back or stopped responding to other treatments. About 60 participants will take a pill (cemsidomide) and receive an injection (elranatamab) to see how well they are toler…
Phase: PHASE1 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New drug combo tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing whether a new drug called cemsidomide, when given with a standard steroid (dexamethasone), can help control multiple myeloma that has come back or stopped responding to other treatments. It is for adults who have already tried at least three different types …
Phase: PHASE2 • Sponsor: C4 Therapeutics, Inc. • Aim: Disease control
Last updated Feb 27, 2026 15:05 UTC